Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More

Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct

Net Sales are expected to decrease by 4.4 percent Y-o-Y (up 1.1 percent Q-o-Q) to Rs. 516.6 crore, according to ICICI Direct.

October 12, 2018 / 03:32 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct has come out with its second quarter (July-September’ 18) earnings estimates for the Healthcare sector. The brokerage house expects Ajanta Pharma to report net profit at Rs. 110.1 crore down 16.5% year-on-year (up 4.1% quarter-on-quarter).


Net Sales are expected to decrease by 4.4 percent Y-o-Y (up 1.1 percent Q-o-Q) to Rs. 516.6 crore, according to ICICI Direct.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 16.1 percent Y-o-Y (down 2.1 percent Q-o-Q) to Rs. 154.2 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

stay updated

Get Daily News on your Browser
Sections